Makya Iktos
![](https://iktos.ai/wp-content/uploads/2022/04/Screenshot-2022-04-21-at-15.30.25.png)
Makya is the first user-friendly SaaS platform for AI-driven de novo drug design focused on Multi-Parametric Optimization (MPO).
![](https://www.degruyter.com/document/doi/10.1515/ci-2022-0106/asset/graphic/j_ci-2022-0106_fig_002.jpg)
Key points to succeed in Artificial Intelligence drug discovery projects
![](https://iktos.ai/wp-content/uploads/2022/03/10.png)
Makya Iktos
![](https://www.actuia.com/wp-content/uploads/2022/04/Iktos-collaboration-Ono-Pharmaceuticals-conception-nouveaux-medicaments-intelligence-artificielle.png)
Iktos announces collaboration with Ono Pharmaceuticals to design new drugs using artificial intelligence - ActuIA
![](https://image.acecamptech.com/articles/20211208/20676a738134.jpg)
恒瑞医药与法国Iktos达成AI新药研发平台战略合作
![](https://mms.businesswire.com/media/20230608005109/en/1813502/22/logo.jpg)
Iktos and Curreio Announce Collaboration Agreement in New Drug Discovery
![](https://pbs.twimg.com/profile_images/982233789064605696/QYhd87qh_400x400.jpg)
IktosAI (@IktosAI) / X
![](https://iktos.ai/wp-content/uploads/2022/09/22.png)
Drug Discovery using Artificial Intelligence
![](https://ask.qcloudimg.com/http-save/yehe-8656663/2665c14168c268803b081ea1d7ead303.png)
Iktos与Galapagos在AI药物设计方面开展合作-腾讯云开发者社区-腾讯云
Iktos announces the appointment of Avirup Bose as Chief Business Officer